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Abstract Translocation of bacteria, primarily
Gram-negative pathogenic flora, from the intestinal
lumen into the circulatory system leads to sepsis. In
newborns, and especially very low birth weight
infants, sepsis is a major cause of morbidity and
mortality. The results of recently conducted clinical
trials suggest that lactoferrin, an iron-binding protein
that is abundant in mammalian colostrum and milk,
may be an effective agent in preventing sepsis in
newborns. However, despite numerous basic studies
on lactoferrin, very little is known about how metal
saturation of this protein affects a host’s health.
Therefore, the main objective of this study was to
elucidate how iron-depleted, iron-saturated, and man-
ganese-saturated forms of lactoferrin regulate
intestinal barrier function via interactions with epithe-
lial cells and macrophages. For these studies, a human
intestinal epithelial cell line, Caco-2, was used. In this
model, none of the tested lactoferrin forms induced
higher levels of apoptosis or necrosis. There was also
no change in the production of tight junction proteins
regardless of lactoferrin metal saturation status. None
of the tested forms induced a pro-inflammatory
response in Caco-2 cells or in macrophages either.
However, the various lactoferrin forms did effectively
inhibit the pro-inflammatory response in macrophages
that were activated with lipopolysaccharide with the
most potent effect observed for apolactoferrin. Lacto-
ferrin that was not bound to its cognate receptor was
able to bind and neutralize lipopolysaccharide. Lacto-
ferrin was also able to neutralize microbial-derived
antigens, thereby potentially reducing their pro-in-
flammatory effect. Therefore, we hypothesize that
lactoferrin supplementation is a relevant strategy for
preventing sepsis.
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Introduction
Despite advances in contemporary neonatology and
superior hygienic conditions, infections continue to
affect newborns. Neonates with a very low birth
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weight (VLBW; e.g.,\1500 g) are at particular risk of
bloodstream infections which are associated with high
rates of morbidity and mortality (Lawn et al. 2006;
Shane and Stoll 2014). The infections may originate
from a hospital environment or may arise from the
translocation of microorganisms from the intestinal
lumen to the peripheral blood supply. Disruption of
mucosal barrier function can occur following a
compromise of intestinal epithelial cell integrity, in
the presence of immune cells of the mucosa-associated
lymphoid tissue (MALT) system, and during the
infiltration of inflammatory cells which facilitates the
translocation of microorganisms (Deitch 2012; Sher-
man 2010).
In full-term newborns, microbiota originating from
their mothers’ urogenital and gastrointestinal tract
undergo natural colonization. However, this coloniza-
tion is disturbed in VLBW infants with a lack of
breastfeeding and during antibiotic treatment. As a
result, a decrease in the population numbers of
beneficial bacteria, such as Bifidobacterium and
Lactobacillus genera, occurs in a newborn’s gastroin-
testinal tract (Gritz and Bhandari 2015). In addition,
gut microbiota of VLBW neonates become populated
with potentially pathogenic species of Enterobacteri-
aceae (e.g., Escherichia coli, Klebsiella pneumoniae)
and Staphylococcaceae (e.g., Staphylococcus aureus)
families. Intestinal dysbiosis, as well as immaturity of
the gut and mucosal immunity, then contribute to a
loss of epithelium integrity and the translocation of
microorganisms from the lumen to the peripheral
blood supply.
Lactoferrin (Lf) is an 80-kDa glycoprotein that
belongs to the transferrin family and is abundant in the
colostrum and milk of mammals. The concentration of
Lf in colostrum is 5–13 g/l and it is 1.5–4.5 g/l in milk
(Hamosh 1998; Ronayne de Ferrer et al. 2000).
Therefore, it is plausible that this protein may play
an important role during neonatal development when
the daily supply of Lf in an infant ranges from 0.4 g to
1.2 g/kg body weight (Sa´nchez et al. 1992).
Iron is an element that is crucial for the growth of
most microorganisms which have developed efficient
mechanisms for uptake of this metal. Lf is capable of
binding two ferric ions with very high affinity, and it is
this property that is typically associated with the
antimicrobial activity of Lf (Aisen and Leibman 1972;
Baker et al. 1994; Paulsson et al. 1993). Two
additional forms of Lf include a metal-free form,
known as apolactoferrin (apoLf), and an iron-saturated
form named hololactoferrin (holoLf). Lf can also bind
other metals in its two binding sites. Recently, we
described the synthesis and prebiotic properties of a
manganese-saturated form of Lf, MnLf, towards
several Lactobacillus strains (manuscript in review).
However, while many publications have described
the mechanism of metal binding by Lf, the impact of
lactoferrin metal saturation status has been not
explored enough in the context of bacterial transloca-
tion. Firstly, apolactoferrin used in previous studies
was estimated to be 10 % iron-saturated which is
saturation commonly found in the native protein
preparations (Goldoni et al. 2000; Marchetti et al.
1998; Superti et al. 2001; Valenti et al. 1999). Our aim
was to reach minimal possible iron saturation and
compare such apolactoferrin activity with that of a
native protein as well as forms with significant
saturation with iron and manganese. Also, we focused
on evaluating importance of iron saturation status of
lactoferrin for bacterial translocation in the context of
neonatal sepsis. Reports on manganese-saturated
lactoferrin have been mostly focused on its potential
to mitigate intracellular infections with both viruses
(HSV1, SA-11) (Marchetti et al. 1998; Superti et al.
2001) and bacteria such as Listeria monocytogenes
and Legionella pneumophila (Goldoni et al. 2000;
Valenti et al. 1999). To our best knowledge, lactofer-
rin saturated with manganese have not been reported
in studies related to maintaining intestinal epithelium
cells integrity and limiting inflammatory response to
microbial antigens in the gut.
The presence of Lf at high concentrations in human
colostrum (*7 g/l) and milk (1–2 g/l) suggests the
importance of this protein in maintaining homeostasis
in the neonatal gut niche. Human Lf is known to bind a
specific receptor (LfR) that is expressed by intestinal
epithelium cells and may be internalized upon binding
(Suzuki et al. 2001). At high concentrations (e.g.,
[100 lg/ml), both bovine and human Lf induces the
proliferation of enterocytes, whereas lower concen-
trations of Lf (e.g.,\100 lg/ml) promote the differ-
entiation of enterocytes (Blais et al. 2014; Buccigrossi
et al. 2007). In an in vitro model of epithelial cells,
human Lf has been shown to increase the integrity of
Caco-2 cells based on measurements of electrical
resistance and dextran permeability (Hirotani et al.
2008). However, the impact of Lf on tight junction
proteins (e.g., claudin, occludin) has not been
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described in the literature despite the role of these
proteins in maintaining the integrity of the intestinal
epithelium. It is also worth mentioning that native
bovine Lf has not exhibited toxicity across a wide
range of concentrations and does not induce apoptosis
or necrosis in epithelial cells in vitro (Ajello et al.
2002).
In addition to antimicrobial activities, Lf may also
affect the immune response. It has been hypothesized
that Lf plays a role in the innate immune system that
provides a first line of defense against infections
(Legrand 2011). The latter activity is based on
interactions between Lf and bacteria-derived mole-
cules, particularly lipopolysaccharide (LPS). For
example, human Lf was shown to bind and neutralize
lipid A of LPS, thereby preventing lipid A-mediated
stimulation of immune cells (Appelmelk et al. 1994;
Legrand et al. 2005). It has also been demonstrated
that LPS binding by both human and bovine Lf affects
the production of cytokines and reactive oxygen
species (Ambruso and Johnston 1981; Baveye et al.
2000; Ha˚versen et al. 2002). However, there are no
data available on whether the various forms of Lf
differentially affect the immune response.
Bovine Lf is a promising therapeutic agent that has
already been tested in a few clinical trials (Manzoni
et al. 2009, 2012; Ochoa et al. 2015). In most of these
trials, native bovine Lf with an unknown level of iron
saturation was used. It is important to note that the
metal saturation status of a protein has the potential to
affect the conformation and possible interactions of
the protein with other molecules. As a result, metal
saturation status may alter the biological activity of Lf.
Therefore, it is crucial to perform basic studies
regarding the mode(s) of action of the various Lf
forms in relevant models.
The present study had three aims. The first was to
evaluate the biological activities of various bovine Lf
forms that differ in their metal saturation levels.
Namely, apoLf, holoLf, and MnLf were compared
with naturally occurring (native) Lf. A high concen-
tration was used for each of the forms (5 mg/ml) based
on the levels of Lf that have been detected in human
colostrum and the levels used for diet supplementation
of VLBW neonates. We especially focused on the role
of the different iron and manganese saturation levels
of Lf on the viability and integrity of the intestinal
epithelium barrier that is dependent on the presence of
tight junctions. Second, we investigated whether metal
binding by Lf affects the intestinal epithelium and the
ability of immune cells to secrete pro- and anti-
inflammatory cytokines. Third, we attempted to con-
firm whether various Lf forms retain the native ability
of Lf to diminish the inflammatory response by
interacting with bacterial components such as LPS.
Materials and methods
Lf preparations
Bovine Lf was purchased from Friesland Campina,
Netherlands. Chemical purity of the native Lf prepa-
ration was estimated to be [90 % and its iron
saturation ca. 10.2 ± 0.2 %. ApoLf and holoLf were
prepared as previously described (Majka et al. 2013)
with iron saturation values of 1.2 ± 0.2 and
71.8 ± 6.5 %, respectively. To obtain apoLf, the
original Lf preparation was dialysed against 0.1 M
citrate buffer (pH 4.0) for 24 h to remove ferric ions.
The buffer was then exchanged with deionized water
for a dialysis step that was performed over 24 h.
HoloLf was prepared by reacting an original Lf
preparation with ferric nitrate(V) in the presence of a
weak chelating agent, nitrilotriacetic acid (NTA), in a
molar ratio of 1:4:4 of Lf:ferric ions:NTA. MnLf
(47.1 ± 2.0 % manganese saturation) was prepared
using reaction with manganese(II) citrate (prepared by
reaction of manganese(II) chloride hydrate and citric
acid). Briefly, ferric ions were removed (as described
for apoLf) and then the metal-deficient Lf was reacted
with 20-fold molar excess of manganese in HEPES
buffer (pH 7.5, 100 mM NaCl, 25 mM NaHCO3) for
24 h at 37 C. Both holoLf and MnLf were subjected
to further dialysis against deionized water (24 h in
room temperature with three changes of water) to
remove nonspecifically bound metals. Iron and man-
ganese saturation was estimated using ICP-OES
(metal content) and ELISA (Lf concentration) and
summarized in Table 1.
Cell culture
A. The human intestinal epithelial cell line, Caco-2
(ATCC HTB-37TM), was purchased from Amer-
ican Type Culture Collection (ATCC). Cells were
cultured in Minimum Essential Medium (MEM)
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containing 2 mM L-glutamine (Lonza, Switzer-
land), 5 % fetal bovine serum (FBS), and antibi-
otics (penicillin/streptomycin) at 37 C in a
humidified 5 % CO2 atmosphere. Cells were
passaged every 3–5 days using trypsin.
B. Human monocyte-derived macrophages
(hMDMs) were isolated from peripheral blood
mononuclear cells donated by healthy donors to
the Red Cross (Krako´w, Poland). Since the Red
Cross deidentifies blood materials, as is appropri-
ate for human subject confidentiality assurances,
consent from patients or approval by any institu-
tional review board for use of these blood
materials was not necessary. Peripheral blood
mononuclear cells (PBMCs) were isolated from
human blood using a lymphocyte separation
medium density gradient that yielded a fraction
that was highly enriched in monocytes (90 %
CD14-positive), as described previously (Koziel
et al. 2014). These cells were subsequently
cultured in RPMI 1640 (Lonza, Switzerland) that
was supplemented with 2 mM L-glutamine,
50 lg/ml gentamycin, and 10 % autological
human serum. Cells were plated at 3 9 106/well
in 24-well plates (Sarstedt, Numbrecht, Germany)
in RPMI 1640 supplemented with 2 mM L-glu-
tamine, 50 lg/ml gentamycin, and 10 % autolog-
ical human serum. After 24 h, nonadherent
PBMCs were removed by washing with complete
medium, and adherent cells were cultured in this
medium for 7 days, with media changed every
2 days up to their differentation into hMDMs.
C. The murine monocyte/macrophage cell line,
J774A.1 (ATCC TIB-67TM), was purchased
from ATCC. Cells were cultured in High-Glucose
Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 2 mM L-glutamine, 10 %
FBS, and antibiotics (penicillin/streptomycin).
The cells were cultured for 5–7 days before being
used for experiments.
Apoptosis/necrosis assay
Briefly, Caco-2 cells were seeded in 24-well plates
(5 9 105 cells/well) in medium containing 5 % FBS.
When the cells reached 100 % confluence, the cells
were incubated with the various Lf forms, each at a
concentration of 5 mg/ml. After 24 h, the cells were
washed twice with PBS and then were stained with
reagents from an Annexin-V-FLUOS Staining Kit
(Roche Diagnostics GmbH, Germany). Cell nuclei
were counterstained with 5 lg/ml Hoechst 33342 (Life
Technologies, USA). A fluorescence microscope,
BX51 (Olympus Europe, Germany), with the appropri-
ate filters was used to count the number of apoptotic
cells (Annexin V-positive cells) and the number of
necrotic cells (stained with propidium iodide) in five
random fields of view. These numbers were compared
with the total number of cells present (based on Hoechst
staining) and the results are presented as percentages.
Immunofluorescent staining of tight junctions
Briefly, Caco-2 cells were seeded in 24-well plates
(5 x 105 cells/well) in medium containing 5 % FBS.
After reaching 100 % confluence, the various forms of
Lf (each 5 mg/ml) were added to the cells. After 24 h,
the cells were washed twice with PBS and then were
fixed for 5 min with methanol at 20 C. After
additional two washes with PBS, the cells were
stained with a FITC-conjugated anti-occludin anti-
body (2.5 lg/ml, OC-3F10, Invitrogen, USA) over-
night at 4 C. A semiquantitative scale from 0 to 3 was
used to indicate the absence, low levels, intermediate
levels, and high levels of tight junction protein
expression, respectively (Fig. 1).
Cytokine production by resting and activated cells
I. The impact of the various Lf forms on secreted
levels of pro- and anti-inflammatory cytokines in
three in vitro cell culture models: Caco-2 cells
(A), hMDMs (B), and J774A.1 cells (C).
A. Caco-2 cells were plated as described in the
apoptosis/necrosis assay. After reaching
Table 1 Iron and manganese saturation of bovine lactoferrin
preparations
Lf form Fe (%) Mn (%)
apoLf 1.2 ± 0.2 Less than 0.5
nLf 10.2 ± 0.2 Less than 0.5
holoLf 71.8 ± 6.5 Less than 0.5
MnLf Less than 0.5 47.1 ± 2.0
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100 % confluence, the various Lf forms were
added to a final concentration of 5 mg/ml.
After 24 h, supernatants were collected and
assayed.
B. Differentiated hMDMs after medium exchage
into 0.5 % autological human serum medium
were stimulated with the various Lf forms in a
final concentration 5 mg/ml. Supernatants
were collected 24 h later.
C. J774A.1 cells were plated in 0.5 % FBS
medium in 24-well plates (1 x 106 cells/well).
After the various Lf forms were added to a
final concentration of 5 mg/ml for each,
supernatants were collected 24 h later.
II. To evaluate the influence of the various Lf forms
on the secretion of pro-inflammatory cytokines by
immune cells activated by the presence of bacte-
ria-derived molecules, two cell culture models
were used: hMDMs and J774A.1 cells. Each set of
cells was propagated and plated prior to these
experiments as described above.
A. The hMDMs were incubated with the various
Lf forms at a concentration of 5 mg/ml. After
30 min, LPS (from E. coli O111:B4, Sigma-
Aldrich) was added at a concentration of
10 ng/ml. The reverse sequence of additions
(e.g., addition of LPS prior to addition of the
various Lf forms) was performed as well.
Supernatants were then collected 8 and 24 h
later.
B. J774A.1 cells were incubated with the various
Lf forms at a concentration of 5 mg/ml. After
Fig. 1 Fluorescent intensity corresponding to different levels
of occludin expression in Caco-2 cells stained with a FITC-
conjugated anti-occludin antibody. The semiquantitative scale
used is represented in the images shown, with 0–3 indicating an
absence, low levels, intermediate levels, or high levels of tight
junction protein expression, respectively
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30 min, LPS (100 ng/ml) or an E. coli
CM226 strain suspension was added. A
suspension of thermally inactivated E. coli
CM226 was used at a concentration corre-
sponding to 107 colony forming units per ml.
This strain was isolated from the blood of
VLBW newborns with clinical symptoms of
sepsis. Prior to its use, the bacterial suspen-
sion in sterile phosphate-buffered saline was
autoclaved at 121 C and 1.02 bar pressure
for 15 min. The reverse sequence of additions
(e.g., addition of the bacteria-derived mole-
cules prior to the various Lf forms) was
performed as well. Supernatants were col-
lected 24 h later.
C. J774A.1 cells were propagated and incubated
with the Lf forms (each at a concentration of
5 mg/ml) and LPS (100 ng/ml) as described
in B. Minor modifications to this procedure
included:
1. LPS stimulation was maintained for 3 h
prior to the addition of nLf.
2. The cell culture medium was changed
after the incubation with nLf and prior to
the addition of LPS.
Cell supernatants were analyzed for levels of IL-1b,
IL-6, IL-10, and TNF-a by using commercially
available enzyme-linked immunosorbent assays (ELI-
SAs) (BD Biosciences, San Jose, CA, USA) according
to the manufacturer’s instructions.
Statistical analysis
Statistical significance of differences between groups
was analyzed using one-way analysis of variance
(ANOVA) with post hoc Tukey’s multiple comparison
test if significant differences were observed. A p value
\0.05 was considered statistically significant. Anal-
ysis was performed using GraphPad Prism v. 5.01
(GraphPad Software, Inc., LaJolla, CA, USA).
Results
Effects of the various Lf forms on apoptosis
and necrosis levels in Caco-2 cells
Lf enters the gastrointestinal passage during breast-
feeding and undergoes partial degradation due to the
acidic pH of the stomach (Fredrikzon and Hernell
1977; Hamosh et al. 1978; Roman et al. 2007).
However, intact Lf has been detected in the stools of
infants (Goldman et al. 1990). Therefore, we studied
the interactions of various Lf species in a relevant
model of human intestinal epithelium, the Caco-2 cell
line. No statistically significant differences in the
percentages of apoptotic and necrotic cells were
detected following incubation of the Caco-2 cells
with the various Lf forms tested (Table 2). Based on
these results, it is predicted that none of the tested Lf
forms should exert cytotoxic effects on human
intestinal epithelial cells.
Effects of the various Lf forms on tight junction
proteins
Integrity of the intestinal epithelium is determined by
enterocyte cell viability and the presence of functional
junctions between enterocyte cells. The latter are
responsible for maintaining an efficient barrier
between the intestinal lumen and surrounding tissues.
Tight junctions are commonly composed of proteins
such as claudin and occludin. When the Caco-2 cell
Table 2 Incubations of Caco-2 cells with the various Lf forms did not result in higher levels of apoptosis or necrosis
Sample Living cells (%) Apoptotic cells (%) Necrotic cells (%)
DMEM - control 95.2 ± 0.3 0.12 ± 0.03 4.7 ± 0.2
apoLf (5 mg/ml) 94.6 ± 0.2 0.13 ± 0.02 5.3 ± 0.1
nLf (5 mg/ml) 94.6 ± 0.2 0.14 ± 0.02 5.3 ± 0.1
holoLf (5 mg/ml) 95.8 ± 0.2 0.10 ± 0.01 4.1 ± 0.1
MnLf (5 mg/ml) 96.2 ± 0.3 0.14 ± 0.02 3.7 ± 0.2
The values presented were calculated using data obtained from three independent experiments with each sample run in duplicate
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line was incubated with the various Lf forms and then
stained with an anti-occludin antibody, none of the
tested Lf forms were found to affect the levels of
occludin in the monolayer (Fig. 2). These results
suggest that Lf does not enhance the formation of tight
junctions, although it may preserve them.
Fig. 2 Lfs do not compromise the function of an epithelial
barrier that is maintained by production of tight junction
proteins. Immunofluorescent staining of occludin expression in
Caco-2 cells is presented under stationary growth conditions
(a and following incubation of the cells with apoLf, (b) nLf, (c)
holoLf, (d) and MnLf, (e) with each Lf form present at a
concentration of 5 mg/ml. The images are representative of
three independent experiments that included duplicates of each
sample
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The various Lf forms tested do not affect cytokine
secretion by resting cells
The secretion of several cytokines was detected after
incubating Caco-2 cells and both human and murine
macrophages (hMDMs and J774A.1 cells, respec-
tively) with the various Lf forms. The levels detected
for IL-1b, IL-6, TNF-a, and IL-10 were close to the
detection limit of the ELISA kits used (data not
shown). Therefore, we conclude that the Lf forms do
not stimulate the secretion of the cytokines detected in
either intestinal epithelial cells or macrophages.
The various Lf forms inhibit secretion of pro-
inflammatory cytokines by activated macrophages
We also studied possible effects of the various Lf
forms on LPS-dependent activation of human macro-
phages. In these experiments, secretion of IL-6 and
TNF-a following LPS stimulation for 8 and 24 h were
significantly inhibited in the presence of the various Lf
forms (Fig. 3). The sequence of LPS and Lf additions
also did not affect the degree of inhibition detected.
There was no statistically significant difference
between the inhibition achieved with the various Lf
Fig. 3 Secretion of pro-inflammatory cytokines induced by
LPS stimulation of hMDMs was inhibited by the various Lf
forms. IL-6 (a, c) and TNF-a (b, d) secretion after 8 h (a, b) and
24 h (c, d) in the presence of the various Lf forms: A apoLf,
N nLf, H holoLf, Mn MnLf, or LPS lipopolysaccharide (100 ng/
ml) are shown. Data in the graph represent the mean ± SEM
from a representative experiment. The samples were analyzed in
duplicate and were repeated with hMDMs obtained from two
donors. Statistical significance was evaluated in comparison
with hMDMs that were incubated only with LPS. *p\ 0.05,
***p\ 0.001
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forms. However, we observed that increased iron
saturation of Lf was found to correspond with a less
pronounced inhibition of LPS stimulation in the case
of detected TNF-a levels (Fig. 3b and d). In compar-
ison with other Lf forms, apoLf exhibited the most
potent inhibitory effect when it was added to the cell
culture prior to LPS.
To elucidate the mechanism(s) mediating the
influence of the various Lf forms on cytokine secretion
by activated immune cells, a well-established model
employing the murine monocyte/macrophage
J774A.1 cell line was used. The cells were incubated
with the various Lf forms in combination with either
LPS or thermally inactivated E. coli CM226. All of the
tested Lf forms retained an ability to inhibit LPS-
induced secretion of the pro-inflammatory cytokines,
IL-6 and TNF-a (Fig. 4). Moreover, the observed
differences were statistically significant for all of the
Lf forms. However, the most potent inhibitory effect
was observed for apoLf for both IL-6 and TNF-a.
When E. coli cells were used as a stimulating agent
instead of LPS, the inhibitory effect on the secretion of
pro-inflammatory cytokines by the various Lf forms
was reduced (Fig. 5). Only a significant difference in
the TNF-a levels that were detected after apoLf was
added to the J774A.1 cells stimulated with E. coli
CM226 was observed (Fig. 5b). However, in most
cases, only minor inhibition of IL-6 and TNF-a
secretion were detected. Again, for TNF-a levels, we
found apoLf to be the most potent form to inhibit the
pro-inflammatory response. These results support the
importance of Lf interactions with LPS, and they also
suggest that the anti-inflammatory activity of Lf is not
as potent when a more complex mixture of bacterial
antigens is used for the stimulation of immune cells.
Lf–LPS interactions are crucial for the anti-
inflammatory activity of Lf
To elucidate whether the secretion of cytokines by
activated immune cells is dependent on the binding of
Lf to its cognate receptor on macrophages or the direct
binding and neutralization of LPS, we introduced
several modifications to the experimental model
described above. Instead of adding only a single agent
(Lf or LPS) or two agents sequentially within a short
time frame (Fig. 6a–c), we delayed the addition of Lf
to the LPS-stimulated cells from 30 min to 3 h. The
levels of secreted IL-6 and TNF-a following LPS
treatment versus E. coli CM226 treatment were 3
versus 27 % and 11 versus 55 %, respectively in each
case. Thus, Lf-dependent inhibition of cytokine pro-
duction was reduced (Table 3).
Furthermore, when the cell culture medium was
changed after the nLf incubation, LPS-induced secre-
tion of proinflammatory cytokines was only partially
inhibited by Lf. For example, the maximal response
percentage increased from 3 to 83 % for IL-6 and from
24 to 52 % for TNF-a (Fig. 6d; Table 3). These results
confirm that binding of Lf by macrophage does not
Fig. 4 Lf forms inhibited the secretion of pro-inflammatory
cytokines induced by LPS stimulation in J774A.1 cells.
Secretion of IL-6 (a) and TNF-a (b) were detected 24 h after
the addition of the various Lf forms to J774A.1 cells. A apoLf,
N nLf, H holoLf, Mn MnLf, LPS (100 ng/ml). Data in the graph
represent the mean ± SEM from two independent experiments
that were performed in duplicate. Statistical significance was
evaluated in comparison with J774A.1 cells that were only
incubated with LPS. *p\ 0.05, ***p\ 0.001
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Fig. 5 The impact of the various forms of Lf on the secretion of
pro-inflammatory cytokines by J774A.1 cells in response to
thermally inactivated E. coli CM226. Secretion of IL-6 (a) and
TNF-a (b) were assayed 24 h after being cultured in the
presence of: A apoLf, N nLf, H holoLf, Mn MnLf, or Ec a
suspension of thermally inactivated E. coli CM226. Data in the
graph represent the mean ± SEM from two independent
experiments that included the samples run in duplicate.
Statistical significance was evaluated in comparison with
J774A.1 cells that were only incubated with E. coli226.
*p\ 0.05
Fig. 6 Interactions between Lf and LPS in the presence of
macrophage. a Activation of macrophage with LPS via TLR4
induces the secretion of pro-inflammatory cytokines (IL-6,
TNF-a). b Lf itself does not induce macrophage activation. c. A
mixture of Lf and LPS does not activate macrophage due to the
formation of a Lf–LPS complex that is unable to activate TLR4.
d Free, non-bound Lf is needed to prevent LPS-induced
macrophage activation. Removal of free Lf by a medium
change performed prior to the addition of LPS resulted in an
effective activation of macrophage. MU macrophage cell, Lf
lactoferrin, LPS lipopolysaccharide, LfR lactoferrin receptor,
TLR4 toll-like receptor 4
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affect the secretion of cytokines IL-6 and TNF-a
following stimulation by LPS. Unbound, free Lf
neutralizes LPS and prevents its binding to receptors
on macrophage.
Discussion
Bovine lactoferrin, when taken orally, is considered
safe and it has no known detrimental effects on human
health. Thus, for decades, bovine Lf has been used as a
diet supplement and an additive to infant formula. In
the present study, the effects of a high concentration of
Lf (5 mg/ml) were investigated. This concentration
corresponds to the levels of Lf that are naturally
occurring in human colostrum, the milk that infants
should receive in the first hours of life. Based on the
high concentration of Lf that is present in human
colostrum and milk, it is hypothesized that this protein
plays a crucial role in maintaining homeostasis in the
neonatal gut niche. Such high levels of Lf are also
relevant for diet supplements for neonates, and Lf
supplementation has proven effective in preventing
neonatal sepsis (Manzoni et al. 2009, 2012).
It is commonly accepted that Lf is an important
component of innate immunity and is capable of
interacting with microorganisms (via an iron seques-
tration mechanism) and microbial molecules (by
neutralization of LPS) that are present in the intestinal
lumen. However, Lf may also affect host cells—
including enterocytes and immune cells—that possess
cognate receptors for Lf. For example, Lf has been
shown to affect the proliferation of enterocytes and
their differentiation, and also has a significant impact
on macrophage function via the production of cytoki-
nes and inflammatory intermediates.
Despite a large body of evidence that supports the
beneficial impact of various Lf preparations on human
health, there is still very little information regarding
the mode of action of Lf and whether saturation of the
protein with Fe and Mn affects its function. An aim of
the present study was to elucidate the impact of metal
(Fe, Mn) saturation levels on bovine Lf in regard to its
function in maintaining the gut epithelial barrier that
consists of intestinal epithelial cells, as well as
immune cells of the MALT system.
The present data confirm that Lf does not mediate
an adverse effect on the barrier formed by intestinal
epithelium cells. At a concentration of 5 mg/ml, both
native Lf and the various forms of Lf that differed in
their metal saturation levels (e.g., apoLf, holoLf, and
MnLf) did not induce a cytotoxic effect on the Caco-2
cell line as measured in the apoptosis/necrosis assays
that were performed. The present results are also
consistent with the non-toxic profile of Lf obtained
from various cells lines at similar concentrations
(Ajello et al. 2002; Fillebeen et al. 1999).
Preservation of a functional intestinal barrier relies
heavily upon the formation of specialized intercellular
junctions. Tight junction proteins, such as claudin 1
and occludin, form macromolecular complexes that
make the enterocyte monolayer impermeable to
Table 3 The effect of native lactoferrin (N) on LPS-induced secretion of IL-6 and TNF-a by J774A.1 cells
Sample IL-6 TNF-a
Concentration (pg/ml) Maximal response (%) Concentration (pg/ml) Maximal response (%)
LPS 22,280 ± 5175 100 20,536 ± 2354 100
N ? LPS 700 ± 100 2.8 ± 0.4 4873 ± 1199 23.7 ± 5.8
LPS ? N 785 ± 35 3.1 ± 0.1 2260 ± 381 11.0 ± 1.8
LPS (3 h) ? N 6685 ± 1180 26.6 ± 4.7 11,350 ± 537 55.2 ± 2.6
N-[LPS* 21,086 ± 1766 83.81 ± 7.0 10,640 ± 714 51.8 ± 3.5
The results are expressed as a percentage of maximal response (mean ± SEM from triplicates assayed in one of two independent
experiments)
N ? LPS denotes that LPS was added 30 min after N was added to the cells
LPS ? N denotes that LPS was added 30 min prior to N addition
LPS(3 h) ? N denotes that incubation with LPS was extended to a period of 3 h
N-[LPS* denotes that the medium was changed after the nLf incubation and LPS was added to nLf-free medium
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substances present in the intestinal lumen. Our results
suggest that neither native Lf, nor the forms of Lf that
differed in metal saturation, affected the levels of
occludin in the Caco-2 monolayer. We observed no
change in the production of tight junction proteins
upon incubation with various lactoferrin forms—
however, the stationary level of those junctions was
preserved to the best of our knowledge, these are the
first data regarding the potential influence of Lf on the
presence of occludin in a monolayer. However, we did
not confirm the previous observation that Lf can
decrease the permeability of Caco-2 cells to polysac-
charide molecules (Hirotani et al. 2008) in our model.
When Caco-2 cells were incubated with the various
Lf forms tested, levels of pro- (IL-1b, IL-6, TNF-a)
and anti-inflammatory (IL-10) cytokines were not
detectable. These results indicate that Lf itself, without
a distinction between various metal saturation levels,
does not induce an inflammatory response in entero-
cytes. Such results are in concord with the literature
data based on studies using lower concentrations of Lf
(Berlutti et al. 2006) and confirm that bovine Lf
preparations with different metal saturation levels do
not alter the function of an epithelial cell monolayer.
Since our results clearly suggest that none of the
tested forms of Lf affect the intestinal barrier, it was
subsequently investigated whether the various Lf
forms interact similarly with LPS and E. coli, which
are representative components of gut microbiota. We
also investigated how these interactions might affect
cytokine production by inflammatory cells, particu-
larly macrophages).
The various Lf forms did not induce the secretion of
IL-6 or TNF-a by resting human monocyte-derived
macrophage. However, the various Lf forms inhibited
LPS-induced secretion of both of these pro-inflam-
matory cytokines by hMDMs 8 and 24 h after the
addition of the Lf forms. This same effect was
observed when the various Lf forms were added to
the cell culture medium 30 min before or after LPS
incubation.
Similar results were obtained in our experiments
with a well-described murine macrophage model,
J774A.1 cells. Cytokine secretion by these macro-
phages following LPS activation was inhibited when
the various Lf forms were added prior to, or after, the
addition of LPS to the cell culture medium. These
results indicate that neither binding of LPS, nor
neutralization of LPS, are significantly affected by the
metal saturation status of Lf. However, the strongest
inhibitory effects were associated with the iron-
depleted form of Lf, apoLf, which—to our best
knowledge—has never been shown before. Further-
more, by changing the medium after the nLf stimu-
lation step, we demonstrate that free Lf present in
molar excess is necessary for LPS neutralization.
The results of the present study are in agreement
with the results of other reports on the immunoregu-
latory properties of Lf. It has been determined that Lf
binds lipid A with high affinity, thereby neutralizing
LPS since lipid A is not further recognized by LBP or
by the receptors present on immune cells such as
TLR4 (Jiang and Lo¨nnerdal 2012). At lower concen-
trations (e.g., 0.01–1 lg/ml), human Lf has been
shown to inhibit IL-6 secretion by LPS-activated THP-
1 cells (Mattsby-Baltzer et al. 1996). Similarly, bovine
Lf (0.1–1.0 mg/ml) has been shown to reduce the
secretion of TNF-a by LPS-activated Raw264.7
macrophage and THP-1 cells (Choe and Lee 2000).
Moreover, both human (0.2 mg/ml) and bovine
(0.5 mg/ml) Lf have effectively inhibited the secretion
of several pro-inflammatory cytokines (e.g., TNF-a,
IL-1b, and IL-8) in THP-1 macrophages that were
challenged with LPS (Ha˚versen et al. 2002). A more
recent report demonstrated that pre-treatment, yet not
co-treatment, with bovine Lf (0.125–2 mg/ml) dimin-
ished LPS-induced TNF-a secretion by THP-1 cells
(Tian et al. 2010). Thus, while the results of the present
study are based on experiments that used Lf at a high
concentration (5 mg/ml), these results are in accor-
dance with previous results that were obtained using
lower concentrations of Lf. A higher concentration of
Lf would also be predicted to be more potent in
neutralizing LPS (compared to the conditions
described in the studies above). The inhibitory effect
of Lf on IL-6 and TNF-a secretion was observed in the
present study when Lf was added before or after the
addition of LPS. It is also worth noting that the impact
of Lf’s metal saturation state on the ability of Lf to
neutralize LPS has not previously been elucidated.
Several reports indicate the potential for Lf to
mediate pro-inflammatory effects on immune cells.
For example, bovine Lf at 0.1 mg/ml was shown to
induce the secretion of TNF-a, IL-8, and nitric oxide
(NO) from rat bone marrow-derived macrophages
(Sorimachi et al. 1997). Later reports provide results
that support activation of the NF-jB pathway by
human Lf (0.5 mg/ml) in THP-1 cells (Ando et al.
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2010). Our results are distinct from these studies, and
this may be due to differences in the concentrations of
Lf that were used. In the present study, an Lf
concentration based on maternal colostrum and milk
levels relevant to neonate feeding in the first days of
life was used.
Using murine macrophages we confirmed that the
clear inhibitory effects on pro-inflammatory cytokine
secretion that were observed for LPS-activated
macrophage in the presence of the various Lf forms
tested were not as potent when the immune cells used
were activated by a more complex mixture of
molecules derived from thermally inactivated E. coli.
These results further confirm the importance of Lf
interactions with specific molecules—namely LPS. To
the best of our knowledge, this is the first report of a
comparison of Lf potential to inhibit cytokine produc-
tion by immune cells that employed both LPS and a
mixture of native bacteria-derived molecules.
Another important function of Lf in the intestinal
lumen and at sites of inflammation is its interaction
with cognate receptors on host cells. Lf can be bound
and internalized via specific LfRs that are present on
enterocytes and immune cells. However, there have
been several reports that Lf can stimulate immune
cells via TLRs as well (Ando et al. 2010). The present
results do not confirm the ability of Lf to affect TLRs.
The addition of Lf to macrophage at high concentra-
tions is predicted to achieve a saturation of LfRs that
are present on macrophages. In the present study, the
use of Lf at a high concentration did not affect LPS-
induced responses when free, non-bound Lf was
removed from the culture medium. Therefore, our
results suggest that free Lf is necessary for binding and
neutralizing LPS.
The results of the present study suggest that oral
supplementation with Lf may have a beneficial effect
on the homeostasis of the neonatal gut niche (Fig. 7).
We have shown that Lf is able to neutralize molecules
derived from Gram-negative bacteria—mostly LPS—
and this capacity does not depend on the metal
saturation status of Lf. Furthermore, we have demon-
strated that free Lf present in molar excess (e.g., not
bound to its cognate receptor) is crucial for binding
and neutralizing LPS, as well as preventing interac-
tions between Lf and components of the immune
system. The present data also show that even high
concentrations of Lf do not have a negative influence
on the barrier established by tight junctions within a
Caco-2 monolayer. High doses of Lf are desirable
since they allow LfRs on enterocytes to be saturated
and the excess Lf can neutralize LPS. Our studies did
Fig. 7 Potential impact of Lf on homeostasis of the intestinal
barrier in neonates. a. In the absence of Lf, disruption of the
mucous layer results in a loss of intestinal integrity and the
translocation of microorganisms and microbial-derived antigens
from the intestinal lumen to peripheral tissues. Infiltrating
immune cells also initiate an acute pro-inflammatory response
that is mediated by cytokines such as IL-6 and TNF-a. b. Diet
supplementation with Lf leads to neutralization of microbial
antigens (namely LPS) in the intestinal lumen and a reduced
inflammatory response. MU macrophage, Lf lactoferrin, LPS
lipopolysaccharide, LfR lactoferrin receptor, TLR4 toll-like
receptor 4
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not reveal significant differences in the anti-inflamma-
tory properties of the various Lf forms—however, the
most potent inhibitory effect on the LPS-dependent
activation of the macrophages was noted for apolato-
ferrin. It has previously been demonstrated that native
Lf can inhibit the growth of some pathogenic species. It
is predicted that the apoLf form would also be able to
sequester iron and inhibit the growth of pathogenic
bacteria. However, we believe that manganese-satu-
rated Lf would have a better impact on gut homeostasis
due to its observed prebiotic properties towards Lacto-
bacillus strains. Thus, while the release of manganese
ions from MnLf has the potential to enhance Lacto-
bacillus species growth in the intestinal lumen, apoLf
could bind excess iron present in the gut niche.
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